Prostate cancer in 2017: Advances in imaging. Review uri icon

Overview

abstract

  • In the past year, the results of three studies in the field of prostate cancer imaging — the prostate MR imaging study (PROMIS), an analysis of the cost-effectiveness of various diagnostic strategies based on PROMIS data, and a retrospective analysis of a prostate-specific membrane antigen (PSMA)-directed PET radiopharmaceutical — have been published that could have lasting effects on clinical practice.

publication date

  • December 12, 2017

Research

keywords

  • Prostatic Neoplasms

Identity

PubMed Central ID

  • PMC6673661

Scopus Document Identifier

  • 85041680787

Digital Object Identifier (DOI)

  • 10.1016/j.euf.2016.11.002

PubMed ID

  • 29231198

Additional Document Info

volume

  • 15

issue

  • 2